PDT Partners’s Cardlytics CDLX Stock Holding History

PDT Partners’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,958	Closed	-$1.15M	–	554
2023 Q3	$1.15M	Sell	6,958 -2,468	-26%	-$321K	0.14%	254
2023 Q2	$596K	Buy	9,426 +2,277	+32%	+$138K	0.08%	352
2023 Q1	$243K	Sell	7,149 -2,235	-24%	-$117K	0.03%	489
2022 Q4	$542K	Buy	+9,384	New	+$580K	0.09%	371
2021 Q2	–	Sell	-3,061	Closed	-$3.36M	–	815
2021 Q1	$3.36M	Buy	+3,061	New	+$4.04M	0.24%	169

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return

PDT Partners's CDLX Position: Q4 2023 in Review

PDT Partners sold out of Cardlytics (CDLX) in Q4 2023, closing a stake of 6,958 shares — an estimated $1.15M sold.

PDT Partners first reported a position in CDLX in Q1 2021 and held it in 5 quarters. The position peaked at $3.36M in Q1 2021. 124 funds tracked by Wall St. Rank hold CDLX as of Q4 2023.

PDT Partners reported no remaining Cardlytics position as of Q4 2023 after selling out during the quarter.
PDT Partners sold 6,958 Cardlytics shares in Q4 2023, an estimated $1.15M.
PDT Partners first reported a position in Cardlytics in Q1 2021 and held it in 5 quarters.
PDT Partners's Cardlytics position peaked at $3.36M in Q1 2021.
124 funds tracked by Wall St. Rank held Cardlytics as of Q4 2023.

Based on PDT Partners's 13F filing for Q4 2023, filed 14 Feb 2024.